(Q33840464)

29 July 2017

1 reference

title

Cloak and dagger in the avoidance of immune surveillance (English)

1 reference

29 July 2017

Pinkoski MJ

1

1 reference

PubMed ID

10679393

29 July 2017

Green DR

series ordinal

2

1 reference

PubMed ID

10679393

29 July 2017

language of work or name

1 reference

1 February 2000

1 reference

Current Opinion in Genetics & Development

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

1

1 reference

29 July 2017

114-119

1 reference

29 July 2017

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Systemic autoimmune disease as a consequence of defective lymphocyte death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Suicidal tendencies: apoptotic cell death by caspase family proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Tumor expression of Fas ligand (CD95L) and the consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

The Fas counterattack: cancer as a site of immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas and Fas ligand interactions suppress melanoma lung metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Ras signalling and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas ligand: a sensor for DNA damage critical in skin cancer etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Regulation of cell death protease caspase-9 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Impaired Fas response and autoimmunity in Pten+/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas-ligand: privilege and peril

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

A vision of cell death: insights into immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Immune response and myoblasts that express Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2899%2900048-9

7 January 2021

10.1016/S0959-437X(99)00048-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10679393